STLN
The Oncology Institute, Inc. (STLN)
Healthcare • NASDAQ • $6.13-5.18%
- Symbol
- STLN
- Exchange
- NASDAQ
- Sector
- Healthcare
- Industry
- Medical Care Facilities
- Price
- $6.13
- Daily Change
- -5.18%
- Market Cap
- $658.89M
- Trailing P/E
- N/A
- Forward P/E
- N/A
- 52W High
- $7.05
- 52W Low
- $2.32
- Analyst Target
- $9.00
- Dividend Yield
- N/A
- Beta
- 0.42
Starling Oncology, Inc., an oncology company, provides various oncology services in the United States. It operates through three segments: Specialty pharmacy, Patient Services, and Clinical Trials & Other. The company offers physician services, in-house infusion, in-house specialty pharmacy, clinical trials, radiation therapy, and outpatient blood product transfusion services, as well as educational seminars, support groups, counseling services, and 24/7 patient assistance and support services. It also manages clinical trials and palliative care programs; operates combined community clinics and infusion suites; and operates a specialty pharmacy that includes both in-office and mail-order dispensing for complementary oral and self-injectable medications taken by patients concurrent with the…
Company websiteResearch STLN on Stk-Ai
Stk-Ai gives you screening across 100+ fundamental metrics, AI-powered analysis, target predictions, backtested signals, and portfolio tracking — all in one place.
Data shown is for informational purposes only and is not investment advice. Prices and metrics may be delayed.